Detected ·
Cloverleaf Bio
$33M—
Cloverleaf Bio closed an upsized, oversubscribed $33M seed round led by 4BIO Capital, with participation from AbbVie Ventures, Eli Lilly, and Boehringer Ingelheim Venture Fund, to advance its novel tRNA-based cancer therapeutics platform.
- Website
- cloverleafbio.com
- Amount
- $33 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-09 04:21:17 UTC
- Signal ID
- 9ded8c97-4de5-48e2-b7aa-5d9a0476ff07
As the API returns it
{
"id": "9ded8c97-4de5-48e2-b7aa-5d9a0476ff07",
"created_at": "2026-09-09T04:21:17.061632Z",
"company_name": "Cloverleaf Bio",
"company_website_url": "cloverleafbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/cloverleaf-bio",
"event_type": "funding",
"funding_amount": 33000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Cloverleaf Bio closed an upsized, oversubscribed $33M seed round led by 4BIO Capital, with participation from AbbVie Ventures, Eli Lilly, and Boehringer Ingelheim Venture Fund, to advance its novel tRNA-based cancer therapeutics platform.*"
}